Kydaliv-Forte Infusion

The infusion is indicated for use in both acute and chronic hepatic encephalopathy to improve neurological symptoms and prevent progression of encephalopathy. Administered intravenously, Kydaliv-Forte facilitates rapid systemic absorption and prompt therapeutic effects. It is essential to monitor liver function tests and ammonia levels during treatment to assess efficacy and adjust dosing accordingly.

The infusion should be used under strict medical supervision, especially in patients with severe hepatic impairment or concomitant renal dysfunction. Adverse effects are generally mild but may include local injection site reactions, gastrointestinal disturbances, or allergic responses. Kydaliv-Forte Infusion is contraindicated in patients with known hypersensitivity to L-Ornithine L-Aspartate or any excipients.

Proper hydration and supportive care are recommended to optimize clinical outcomes. This product should be stored according to manufacturer guidelines and used within the specified shelf life to ensure potency and safety.